Претраживање
Приказ резултата 11-19 од 19
Recovery after severe brain injury
(Lippincott Williams & Wilkins, Philadelphia, 2008)
Oxidative Stress-Mediated Activation of AKT/mTOR Signaling Pathway Leads to Myeloproliferative Syndrome in FoxO3 Null Mice: A Role for Lnk Adaptor Protein
(Amer Soc Hematology, Washington, 2008)
The influence of manifest strabismus and stereoscopic vision on non-verbal abilities of visually impaired children
(Pergamon-Elsevier Science Ltd, Oxford, 2011)
This research was conducted in order to examine the influence of manifest strabismus and stereoscopic vision on non-verbal abilities. of visually impaired children aged between 7 and 15. The sample included 55 visually ...
Students' and teachers' perceptions of aggressive behaviour in adolescents with intellectual disability and typically developing adolescents
(Pergamon-Elsevier Science Ltd, Oxford, 2013)
This study investigated aggressive behaviour in Serbian adolescents with intellectual disability (ID) compared to typically developing peers. The sample consisted of both male and female adolescents aged 12-18 years. One ...
Dysgraphic Handwriting in Gypsy and Non-Gypsy Children
(Lippincott Williams & Wilkins, Philadelphia, 2012)
Prenatal Brain Injury-Case Study
(Lippincott Williams & Wilkins, Philadelphia, 2011)
Psychological Abilities in Children with Verbal Apraxia
(Lippincott Williams & Wilkins, Philadelphia, 2013)
Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial
(Elsevier Science Inc, New York, 2020)
Background More than a third of patients with epilepsy are treatment resistant, and thus new, more effective therapies to achieve seizure freedom are needed. Cenobamate (YKP3089), an investigational antiepileptic drug, has ...
Global pattern of experienced and anticipated discrimination reported by people with major depressive disorder: A cross-sectional survey
(Elsevier B.V., 2013)
Background Depression is the third leading contributor to the worldwide burden of disease. We assessed the nature and severity of experienced and anticipated discrimination reported by adults with major depressive disorder ...